Colorectal NeoplasmsColonoscopyAdenomaLeucovorinOrganoplatinum CompoundsCamptothecinColonic PolypsFluorouracilPneumoradiographyNeoplasm MetastasisAntibodies, Monoclonal, HumanizedAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsRectal NeoplasmsColonic Neoplasmsras ProteinsAntibodies, MonoclonalTumor Markers, BiologicalLiver NeoplasmsTreatment OutcomeRectumDisease-Free SurvivalNeoplasm StagingDrug Administration ScheduleChronotherapyDeoxycytidineInfusions, IntravenousPrognosisIntestinal MucosaColonRetrospective StudiesEarly Detection of CancerAntineoplastic AgentsImmunohistochemistrySurvival AnalysisAntimetabolites, AntineoplasticTegafurNeoplasm InvasivenessSurvival RateProto-Oncogene Proteins B-rafCarcinoembryonic AntigenSensitivity and SpecificityReceptor, Epidermal Growth FactorProto-Oncogene ProteinsUracilRisk FactorsAngiogenesis InhibitorsDisease ProgressionCarcinomaKaplan-Meier EstimateColorectal Neoplasms, Hereditary NonpolyposisMutationAntineoplastic Agents, PhytogenicGenes, rasDrug Resistance, NeoplasmPilot ProjectsHepatectomyNeoplasmsDiarrheaClinical Trials, Phase III as TopicOxonic AcidColorectal SurgeryKeratin-20NeutropeniaDNA, NeoplasmInfusions, Intra-ArterialAdministration, OralLung NeoplasmsNauseaKeratin-7Salvage TherapyDNA Mutational AnalysisThymidylate SynthaseProspective StudiesPancreatic NeoplasmsGene Expression Regulation, NeoplasticExanthemaHepatic ArteryNeoplasm Recurrence, LocalDose-Response Relationship, DrugGlucuronosyltransferaseFollow-Up StudiesPalliative CareThiophenesPredictive Value of TestsMaximum Tolerated DoseClinical Trials as TopicQuinazolinesFloxuridineReceptors, Guanylate Cyclase-CoupledClinical Trials, Phase II as TopicDihydrouracil Dehydrogenase (NADP)Vomiting, AnticipatoryTime FactorsNeoplasm ProteinsProportional Hazards ModelsAntidotesRandomized Controlled Trials as TopicGenotypeNeoplasms, Cystic, Mucinous, and Serous